Frankfurt Oral Regenerative Medicine, Clinic for Maxillofacial and Plastic Surgery, Johann Wolfgang Goethe University, Frankfurt Am Main,
Eur Cell Mater. 2019 Apr 9;37:250-264. doi: 10.22203/eCM.v037a15.
Different tissue engineering techniques are used to support rapid vascularisation. A novel technique is the use of platelet-rich fibrin (PRF), an autologous source of growth factors. This study was the first to investigate the influence of PRF matrices, isolated following different centrifugation protocols, on human dermal vascular endothelial cells (ECs) in mono-culture and co-culture with human primary fibroblasts (HFs) as an in vitro model for tissue regeneration. Focus was placed on vascular structure formation and growth factor release. HFs and ECs were cultivated with PRF prepared using a high (710 ×g) or low (44 ×g) relative centrifugation force (RCF) over 14 d. Immunofluorescence staining and immunohistochemistry were used to evaluate the microvascular formation. Cell culture supernatants were collected for evaluation of growth factor release. The results showed a PRF-mediated effect on the induction of angiogenesis in ECs. Microvessel-like structure formation was promoted when ECs were combined with low-RCF PRF as compared to high-RCF PRF or control group. The percentage of vascular lumen area was significantly higher in low-RCF PRF, especially at day 7, which coincided with statistically significantly higher growth factor [vascular endothelial factor (VEGF), transforming growth factor β1 (TGF-β1) and platelet derived growth factor (PDGF)] concentration measured in low-RCF PRF as compared to high-RCF PRF or control group. In conclusion, reducing the RCF according to the low-speed centrifugation concept (LSCC) resulted in increased growth factor release and angiogenic structure formation with EC mono-culture, suggesting that PRF may be a highly beneficial therapeutic tool for tissue engineering applications.
不同的组织工程技术被用于支持快速血管化。一种新的技术是使用富含血小板的纤维蛋白(PRF),这是一种自体来源的生长因子。这项研究首次调查了 PRF 基质的影响,这些基质是根据不同的离心方案分离出来的,用于人类真皮血管内皮细胞(ECs)的单核培养和与人类原代成纤维细胞(HFs)共培养,作为组织再生的体外模型。重点放在血管结构形成和生长因子释放上。HFs 和 ECs 用高(710×g)或低(44×g)相对离心力(RCF)在 14 天内制备的 PRF 培养。免疫荧光染色和免疫组织化学用于评估微血管形成。收集细胞培养上清液以评估生长因子释放。结果表明 PRF 对 ECs 诱导血管生成有影响。与高 RCF PRF 或对照组相比,当 ECs 与低 RCF PRF 结合时,促进了类似微血管的结构形成。低 RCF PRF 中的血管腔面积百分比明显更高,特别是在第 7 天,这与低 RCF PRF 中生长因子[血管内皮生长因子(VEGF)、转化生长因子β1(TGF-β1)和血小板衍生生长因子(PDGF)]浓度的统计学显著增加一致,与高 RCF PRF 或对照组相比。总之,根据低速离心概念(LSCC)降低 RCF 导致 EC 单核培养中生长因子释放和血管生成结构形成增加,这表明 PRF 可能是组织工程应用的一种非常有益的治疗工具。